Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / cellectis pushing a different kind of car t up the h

ALLO - Cellectis: Pushing A Different Kind Of CAR-T Up The Hill

Allogene Therapeutics Inc.

2024-01-22 18:34:33 ET

Summary

  • Cellectis is a biotech company focused on developing allogeneic CAR T-cell therapy, which uses donor T cells instead of the patient's own cells.
  • They have three main projects in clinical studies, with their most advanced therapy being outlicensed to Allogene.
  • The company has an unproven, promising tech with a long developmental lag time, making this something I'm not ready to recommend at this time.

Topline Summary

For further details see:

Cellectis: Pushing A Different Kind Of CAR-T Up The Hill
Stock Information
Company Name: Allogene Therapeutics Inc.
Stock Symbol: ALLO
Market: NASDAQ
Website: allogene.com
Menu
ALLO ALLO Quote ALLO Short ALLO News ALLO Articles ALLO Message Board
Get ALLO Alerts

News, Short Squeeze, Breakout and More Instantly...